已收盤 02-06 16:00:00 美东时间
+3.670
+6.61%
今日重点评级关注:康托·菲茨杰拉德:维持Wave Life Sciences Ltd."超配"评级,目标价从34美元升至41美元;Piper Sandler:维持Replimune Group"超配"评级,目标价从13美元升至14美元
02-06 16:52
华盛资讯2月6日讯,Blue Bird Corporation公布2025财年Q4业绩,公司Q4营收3.33亿美元,同比增长6.1%,归母净利润0.31亿美元,同比增长7.1%。
02-06 02:46
华盛资讯2月6日讯,Blue Bird Corporation公布2026财年Q1业绩,公司Q1营收3.33亿美元,同比增长6.1%,归母净利润0.31亿美元,同比增长7.1%。
02-06 02:17
BTIG analyst Gregory Lewis reiterates Blue Bird (NASDAQ:BLBD) with a Buy and maintains $65 price target.
02-05 18:48
Blue Bird Corp. (BLBD) shares rose 4.2% in extended trading Wednesday after the school bus maker reported quarterly results that beat Wall Street estimates and raised its full-year profitability outlo...
02-05 07:41
Blue Bird (NASDAQ:BLBD) just disclosed its Q1 earnings on Wednesday, February 4...
02-05 05:04
Blue Bird (NASDAQ:BLBD) affirms FY2026 sales outlook from $1.500 billion to $1.500 billion.
02-05 05:04
Blue Bird (NASDAQ:BLBD) reported quarterly earnings of $1.00 per share which beat the analyst consensus estimate of $0.82 by 22.55 percent. This is a 8.7 percent increase over earnings of $0.92 per share from the same
02-05 05:03
Companies Reporting Before The Bell • Oaktree Specialty Lending (NASDAQ:OCSL) i...
02-04 19:11
Blue Bird Corporation to Announce Fiscal 2026 First Quarter Results Blue Bird Corporation will release its fiscal 2026 first quarter results on February 4, 2026. An audio webcast and conference call to discuss the results will be held at 4:30PM ET the same day, featuring President and CEO John Wyski
01-22 01:42